Compare Dar Al Dawa Development & Investment Co. Ltd. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROCE of 8.76%
- The company has been able to generate a Return on Capital Employed (avg) of 8.76% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
3
Positive results in Jan 70
4
With ROE of 9.68%, it has a fair valuation with a 0.82 Price to Book Value
5
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.56%
0%
-6.56%
6 Months
-0.87%
0%
-0.87%
1 Year
2.76%
0%
2.76%
2 Years
-9.01%
0%
-9.01%
3 Years
-11.63%
0%
-11.63%
4 Years
16.33%
0%
16.33%
5 Years
-17.99%
0%
-17.99%
Dar Al Dawa Development & Investment Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.99%
EBIT Growth (5y)
11.06%
EBIT to Interest (avg)
2.02
Debt to EBITDA (avg)
2.90
Net Debt to Equity (avg)
0.66
Sales to Capital Employed (avg)
0.81
Tax Ratio
9.75%
Dividend Payout Ratio
17.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.76%
ROE (avg)
9.51%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.82
EV to EBIT
6.81
EV to EBITDA
4.79
EV to Capital Employed
0.84
EV to Sales
0.86
PEG Ratio
0.39
Dividend Yield
1.83%
ROCE (Latest)
12.39%
ROE (Latest)
9.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
15.10
25.50
-40.78%
Operating Profit (PBDIT) excl Other Income
2.70
6.20
-56.45%
Interest
0.80
1.00
-20.00%
Exceptional Items
-0.00
-0.10
100.00%
Consolidate Net Profit
0.60
3.70
-83.78%
Operating Profit Margin (Excl OI)
111.10%
196.00%
-8.49%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -40.78% vs 36.36% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -83.78% vs 208.33% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
81.60
79.70
2.38%
Operating Profit (PBDIT) excl Other Income
13.40
11.40
17.54%
Interest
3.90
3.90
Exceptional Items
-0.20
-0.10
-100.00%
Consolidate Net Profit
6.60
3.70
78.38%
Operating Profit Margin (Excl OI)
113.30%
93.60%
1.97%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 2.38% vs 6.41% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 78.38% vs 19.35% in Dec 2024
About Dar Al Dawa Development & Investment Co. Ltd. 
Dar Al Dawa Development & Investment Co. Ltd.
Pharmaceuticals & Biotechnology
Dar Al Dawa Development and Investment Company PSC is a Jordan-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical and consumer health products. The Company’s main activities are producing medical, chemical and pharmaceutical products, and importing pharmaceutical products. The Company operates an integrated network of 11 manufacturing facilities spread across Jordan, Middle East and North Africa region, as well as Romania. Its Pharmaceutical Development Unit focuses on the process developing of various dosage forms including tablets, capsules, liquids, dry suspensions, suppositories, creams, ointments, gels, parenterals, ophthalmic and nasal preparations. The Analytical Research unit engages in the analytical method development, validation, physiochemical characterization and stability studies.
Company Coordinates 
Company Details
Dar Al Dawa Dvlpmnt & Instmnt Co Bldg, Wadi Saqrah Street, Al Rabia Area, P.O.Box 9364, AMMAN None : 11191
Registrar Details






